Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF384 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 EZH2 ZNF416 ZNF548 ZNF529 RXRA ZNF354C RXRB CASZ1 ZNF710 ZNF77	9.53e-09	1459	81	23	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF384 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF841 ZNF236 ZNF416 ZNF548 ZNF529 RXRA ZNF354C RXRB CASZ1 ZNF77	6.21e-07	1412	81	20	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF384 ZNF573 ZFAT ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF362 ZNF841 ZNF236 EZH2 ZNF416 ZNF548 RXRA ZNF354C RXRB ZNF710	1.89e-06	1244	81	18	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF384 ZNF573 ZFAT ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF362 ZNF841 ZNF236 EZH2 ZNF416 ZNF548 RXRA ZNF354C RXRB ZNF710	2.56e-06	1271	81	18	GO:0000987
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH17 DNAH2 DNAH9	5.02e-05	18	81	3	GO:0008569
GeneOntologyMolecularFunction	histone H4K20 demethylase activity	PHF2 PHF8	9.70e-05	4	81	2	GO:0035575
GeneOntologyMolecularFunction	histone H4 demethylase activity	PHF2 PHF8	1.61e-04	5	81	2	GO:0141058
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH17 DNAH2 DNAH9	1.96e-04	28	81	3	GO:0051959
GeneOntologyMolecularFunction	zinc ion binding	PHF2 ZMAT5 ZNF326 TUT4 USP51 TRPS1 KMT2A PHF14 PHF8 RXRA RXRB ZMYM4	2.40e-04	891	81	12	GO:0008270
GeneOntologyMolecularFunction	retinoic acid-responsive element binding	RXRA RXRB	3.37e-04	7	81	2	GO:0044323
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH17 DNAH2 DNAH9	4.52e-04	37	81	3	GO:0045505
GeneOntologyMolecularFunction	unmethylated CpG binding	KMT2A TLR9	7.16e-04	10	81	2	GO:0045322
GeneOntologyMolecularFunction	histone binding	PHF2 USP51 ATRX KMT2A PHF14 PHF8	7.29e-04	265	81	6	GO:0042393
GeneOntologyMolecularFunction	transition metal ion binding	PHF2 ZMAT5 ZNF326 TUT4 ATP2C1 USP51 TRPS1 KMT2A PHF14 PHF8 RXRA RXRB ZMYM4	9.46e-04	1189	81	13	GO:0046914
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	FBN1 FBN2	1.04e-03	12	81	2	GO:0030023
GeneOntologyMolecularFunction	histone H3K9 demethylase activity	PHF2 PHF8	1.43e-03	14	81	2	GO:0032454
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	FBN1 FBN2	1.43e-03	14	81	2	GO:0097493
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	RXRA RXRB	2.38e-03	18	81	2	GO:0042809
GeneOntologyMolecularFunction	histone modifying activity	PHF2 USP51 KMT2A PHF8 EZH2	2.40e-03	229	81	5	GO:0140993
GeneOntologyBiologicalProcess	negative regulation of heterochromatin formation	PHF2 KMT2A PHF8	1.11e-06	6	80	3	GO:0031452
GeneOntologyBiologicalProcess	negative regulation of chromatin organization	PHF2 KMT2A PHF8	1.94e-06	7	80	3	GO:1905268
GeneOntologyBiologicalProcess	negative regulation of rDNA heterochromatin formation	PHF2 PHF8	1.49e-05	2	80	2	GO:0061188
GeneOntologyBiologicalProcess	regulation of rDNA heterochromatin formation	PHF2 PHF8	4.45e-05	3	80	2	GO:0061187
GeneOntologyBiologicalProcess	facultative heterochromatin formation	PHF2 KMT2A PHF8 EZH2	6.16e-05	55	80	4	GO:0140718
GeneOntologyBiologicalProcess	sequestering of TGFbeta in extracellular matrix	FBN1 FBN2	8.87e-05	4	80	2	GO:0035583
GeneOntologyBiologicalProcess	negative regulation of amacrine cell differentiation	GDF11 CASZ1	8.87e-05	4	80	2	GO:1902870
GeneOntologyBiologicalProcess	regulation of heterochromatin formation	PHF2 KMT2A PHF8	1.07e-04	24	80	3	GO:0031445
GeneOntologyBiologicalProcess	positive regulation of vitamin D receptor signaling pathway	RXRA RXRB	2.21e-04	6	80	2	GO:0070564
GeneOntologyCellularComponent	dynein complex	DNAH17 DNAH2 DCTN4 DNAH9	5.18e-05	54	79	4	GO:0030286
GeneOntologyCellularComponent	axonemal dynein complex	DNAH17 DNAH2 DNAH9	1.13e-04	25	79	3	GO:0005858
Domain	zf-C2H2	ZNF462 ZNF384 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	8.67e-14	693	80	22	PF00096
Domain	ZINC_FINGER_C2H2_1	ZNF462 ZNF384 ZNF573 TUT4 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	9.12e-14	777	80	23	PS00028
Domain	Znf_C2H2-like	ZNF462 ZNF384 ZNF326 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	1.51e-13	796	80	23	IPR015880
Domain	Znf_C2H2	ZNF462 ZNF384 ZNF326 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	1.91e-13	805	80	23	IPR007087
Domain	ZnF_C2H2	ZNF462 ZNF384 ZNF326 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	2.07e-13	808	80	23	SM00355
Domain	ZINC_FINGER_C2H2_2	ZNF462 ZNF384 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	8.17e-13	775	80	22	PS50157
Domain	-	ZNF462 ZNF384 ZNF573 ZFAT ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C ZNF710 ZNF77	5.63e-12	679	80	20	3.30.160.60
Domain	Znf_C2H2/integrase_DNA-bd	ZNF462 ZNF384 ZNF573 ZFAT ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C ZNF710 ZNF77	8.37e-12	694	80	20	IPR013087
Domain	zf-C2H2_6	ZNF384 ZNF573 ZNF780A ZNF616 ZNF749 ZNF841 ZNF236 ZNF416 ZNF548 ZNF354C ZNF710 ZNF77	8.97e-09	314	80	12	PF13912
Domain	KRAB	ZNF573 ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF416 ZNF548 ZNF529 ZNF354C ZNF77	3.83e-08	358	80	12	PS50805
Domain	KRAB	ZNF573 ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF416 ZNF548 ZNF529 ZNF354C ZNF77	3.83e-08	358	80	12	PF01352
Domain	KRAB	ZNF573 ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF416 ZNF548 ZNF529 ZNF354C ZNF77	5.33e-08	369	80	12	SM00349
Domain	KRAB	ZNF573 ZNF780A ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF416 ZNF548 ZNF529 ZNF354C ZNF77	5.49e-08	370	80	12	IPR001909
Domain	FBN	FBN1 FBN2	5.42e-05	3	80	2	IPR011398
Domain	ZF_PHD_2	PHF2 ATRX KMT2A PHF14 PHF8	5.45e-05	95	80	5	PS50016
Domain	ZF_PHD_1	PHF2 ATRX KMT2A PHF14 PHF8	5.73e-05	96	80	5	PS01359
Domain	FAD-bd	MICAL2 MICAL3	2.69e-04	6	80	2	IPR002938
Domain	FAD_binding_3	MICAL2 MICAL3	2.69e-04	6	80	2	PF01494
Domain	WxxW_domain	MUC5B CEMIP	2.69e-04	6	80	2	IPR025155
Domain	Mucin2_WxxW	MUC5B CEMIP	2.69e-04	6	80	2	PF13330
Domain	PHD	PHF2 KMT2A PHF14 PHF8	3.01e-04	75	80	4	PF00628
Domain	Znf_PHD-finger	PHF2 KMT2A PHF14 PHF8	3.67e-04	79	80	4	IPR019787
Domain	TB	FBN1 FBN2	3.75e-04	7	80	2	PF00683
Domain	Znf_FYVE_PHD	PHF2 ATRX KMT2A PHF14 PHF8	4.22e-04	147	80	5	IPR011011
Domain	DHC_N1	DNAH2 DNAH9	4.99e-04	8	80	2	PF08385
Domain	-	FBN1 FBN2	4.99e-04	8	80	2	3.90.290.10
Domain	Dynein_heavy_dom-1	DNAH2 DNAH9	4.99e-04	8	80	2	IPR013594
Domain	EGF_CA	FBN1 FBN2 SVEP1 NPNT	5.08e-04	86	80	4	PF07645
Domain	PHD	PHF2 KMT2A PHF14 PHF8	5.78e-04	89	80	4	SM00249
Domain	Znf_PHD	PHF2 KMT2A PHF14 PHF8	6.29e-04	91	80	4	IPR001965
Domain	TB	FBN1 FBN2	6.40e-04	9	80	2	PS51364
Domain	TB_dom	FBN1 FBN2	6.40e-04	9	80	2	IPR017878
Domain	-	PHF2 USP51 ATRX COP1 KMT2A PHF14 PHF8 CNOT4	6.69e-04	449	80	8	3.30.40.10
Domain	Znf_RING/FYVE/PHD	PHF2 USP51 ATRX COP1 KMT2A PHF14 PHF8 CNOT4	7.72e-04	459	80	8	IPR013083
Domain	Retinoid-X_rcpt/HNF4	RXRA RXRB	7.97e-04	10	80	2	IPR000003
Domain	EGF_Ca-bd_CS	FBN1 FBN2 SVEP1 NPNT	7.99e-04	97	80	4	IPR018097
Domain	EGF_CA	FBN1 FBN2 SVEP1 NPNT	8.63e-04	99	80	4	PS01187
Domain	ASX_HYDROXYL	FBN1 FBN2 SVEP1 NPNT	8.96e-04	100	80	4	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN1 FBN2 SVEP1 NPNT	1.11e-03	106	80	4	IPR000152
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH9	1.59e-03	14	80	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH9	1.59e-03	14	80	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH9	1.59e-03	14	80	2	IPR013602
Domain	DHC_N2	DNAH2 DNAH9	1.59e-03	14	80	2	PF08393
Domain	MT	DNAH2 DNAH9	1.59e-03	14	80	2	PF12777
Domain	AAA_8	DNAH2 DNAH9	1.59e-03	14	80	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH9	1.59e-03	14	80	2	IPR011704
Domain	AAA_5	DNAH2 DNAH9	1.59e-03	14	80	2	PF07728
Domain	DHC_fam	DNAH2 DNAH9	1.83e-03	15	80	2	IPR026983
Domain	Dynein_heavy_dom	DNAH2 DNAH9	1.83e-03	15	80	2	IPR004273
Domain	Dynein_heavy	DNAH2 DNAH9	1.83e-03	15	80	2	PF03028
Domain	EGF_CA	FBN1 FBN2 SVEP1 NPNT	1.87e-03	122	80	4	SM00179
Domain	-	TRPS1 RXRA RXRB	1.87e-03	57	80	3	3.30.50.10
Domain	Znf_CCCH	PPP1R10 ZMAT5 CNOT4	1.97e-03	58	80	3	IPR000571
Domain	Znf_NHR/GATA	TRPS1 RXRA RXRB	1.97e-03	58	80	3	IPR013088
Domain	ZF_C3H1	PPP1R10 ZMAT5 CNOT4	1.97e-03	58	80	3	PS50103
Domain	EGF-like_Ca-bd_dom	FBN1 FBN2 SVEP1 NPNT	1.98e-03	124	80	4	IPR001881
Domain	GATA_ZN_FINGER_1	ATRX TRPS1	2.09e-03	16	80	2	PS00344
Domain	GATA_ZN_FINGER_2	ATRX TRPS1	2.09e-03	16	80	2	PS50114
Domain	Zinc_finger_PHD-type_CS	PHF2 PHF14 PHF8	2.73e-03	65	80	3	IPR019786
Domain	CH	MICAL2 MICAL3 VAV2	2.73e-03	65	80	3	SM00033
Domain	LIM	PDLIM7 MICAL2 MICAL3	3.24e-03	69	80	3	PF00412
Domain	-	PDLIM7 MICAL2 MICAL3	3.37e-03	70	80	3	2.10.110.10
Domain	CH	MICAL2 MICAL3 VAV2	3.37e-03	70	80	3	PF00307
Domain	Znf_LIM	PDLIM7 MICAL2 MICAL3	3.51e-03	71	80	3	IPR001781
Domain	LIM_DOMAIN_1	PDLIM7 MICAL2 MICAL3	3.51e-03	71	80	3	PS00478
Domain	LIM_DOMAIN_2	PDLIM7 MICAL2 MICAL3	3.51e-03	71	80	3	PS50023
Domain	-	MICAL2 MICAL3 VAV2	3.51e-03	71	80	3	1.10.418.10
Domain	LIM	PDLIM7 MICAL2 MICAL3	3.51e-03	71	80	3	SM00132
Domain	CH	MICAL2 MICAL3 VAV2	3.79e-03	73	80	3	PS50021
Domain	EPHD	KMT2A PHF14	3.96e-03	22	80	2	PS51805
Domain	CH-domain	MICAL2 MICAL3 VAV2	4.09e-03	75	80	3	IPR001715
Domain	Growth_fac_rcpt_	FBN1 FBN2 SVEP1 NPNT	4.53e-03	156	80	4	IPR009030
Domain	JmjC	PHF2 PHF8	4.70e-03	24	80	2	PF02373
Domain	cEGF	FBN1 FBN2	5.51e-03	26	80	2	IPR026823
Domain	cEGF	FBN1 FBN2	5.51e-03	26	80	2	PF12662
Domain	hEGF	FBN2 SVEP1	6.37e-03	28	80	2	PF12661
Domain	JMJC	PHF2 PHF8	8.27e-03	32	80	2	PS51184
Domain	JmjC_dom	PHF2 PHF8	8.27e-03	32	80	2	IPR003347
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH2 DCTN4 DNAH9	6.27e-06	27	64	4	M47755
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	NCBP2 ZNF573 CDC16 ZNF347 KMT2A ZNF616 ZNF264 ZNF215 ZNF749 EZH2 ZNF416 ZNF548 ZNF529 RXRA ZNF354C RXRB CNOT4 ZNF710 ZNF77	7.50e-06	1387	64	19	M734
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH2 DCTN4 DNAH9	4.17e-05	43	64	4	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH17 DNAH2 DCTN4 DNAH9	5.01e-05	45	64	4	M47670
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE	RXRA RXRB	2.01e-04	5	64	2	M29791
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE	RXRA RXRB	2.01e-04	5	64	2	M29792
Pathway	KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION	RXRA RXRB	2.01e-04	5	64	2	M49023
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS	RXRA RXRB	2.01e-04	5	64	2	M29812
Pathway	WP_VITAMIN_A1_AND_A5X_PATHWAYS	RXRA RXRB	3.01e-04	6	64	2	M48097
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	RXRA RXRB	3.01e-04	6	64	2	MM15663
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	ZNF780A ZNF347 KMT2A ZNF616 EZH2 ZNF416 RXRA ZNF354C RXRB CNOT4 ZNF710	6.14e-04	768	64	11	MM14851
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS	RXRA RXRB	7.16e-04	9	64	2	M29789
Pathway	KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY	RXRA RXRB	7.16e-04	9	64	2	M47629
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	RXRA RXRB	7.16e-04	9	64	2	M29809
Pathway	WP_VITAMIN_D_METABOLISM	RXRA RXRB	8.92e-04	10	64	2	M39352
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF462 PHF2 PPP1R10 ZNF384 ATRX ZNF780A KMT2A PHF14 ZNF362 PHF8 EZH2 CHAMP1 CASZ1 ZMYM4	1.34e-10	608	81	14	36089195
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF462 PHF2 PPP1R10 ZMAT5 ZNF326 TRPS1 ZNF347 ZNF616 PHF14 PHF8 ZNF236 RXRA ZNF354C RXRB ZNF710	5.35e-10	808	81	15	20412781
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF462 PHF2 TUT4 ATP2C1 ATRX MICAL2 TRPS1 PHF14 MICAL3 PLCB4 ZNF362 ZNF236 RXRA CASZ1 VAV2 ZMYM4 STT3A	4.75e-08	1489	81	17	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF462 PHF2 ATP2C1 THSD7A DNAH17 ZNF347 ZNF616 PHF14 MICAL3 CASZ1	2.29e-07	493	81	10	15368895
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH17 DNAH2 DNAH9	4.23e-07	7	81	3	31178125
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	FBN1 FBN2 THSD7A ZNF77 SPINK5	6.98e-07	71	81	5	33541421
Pubmed	Human transcription factor protein interaction networks.	ZNF462 PHF2 ZNF326 FBN1 FBN2 PPP6C ATRX TRPS1 COP1 KMT2A PHF8 GARRE1 RXRA ZMYM4 STT3A	9.48e-07	1429	81	15	35140242
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	PHF2 KMT2A PHF8 EZH2	1.06e-06	33	81	4	26864203
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ZNF462 NCBP2 PPP1R10 PPP6C ATRX KMT2A PHF14 EZH2 ZMYM4	1.51e-06	469	81	9	27634302
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF462 PPP1R10 ZNF384 ATP2C1 FBN2 PDLIM7 MICAL2 CTSC ZNF362 CHAMP1 CASZ1 ZMYM4 STT3A	4.02e-06	1203	81	13	29180619
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF780A ZNF264 ZNF749 ZNF841 ZNF529 ZNF77	4.29e-06	181	81	6	37372979
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	ZNF462 KMT2A PHF14 CHAMP1 ZMYM4	4.43e-06	103	81	5	32744500
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	PHF2 KMT2A PHF8 EZH2	5.34e-06	49	81	4	34368113
Pubmed	Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils.	FBN1 FBN2	5.36e-06	2	81	2	12399449
Pubmed	RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis.	RXRA RXRB	5.36e-06	2	81	2	7926783
Pubmed	Fibrillin-1 and fibrillin-2 are essential for formation of thick oxytalan fibers in human nonpigmented ciliary epithelial cells in vitro.	FBN1 FBN2	5.36e-06	2	81	2	21851253
Pubmed	Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences.	FBN1 FBN2	5.36e-06	2	81	2	12429739
Pubmed	ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.	ATRX EZH2	5.36e-06	2	81	2	32194873
Pubmed	New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis.	FBN1 FBN2	5.36e-06	2	81	2	30044367
Pubmed	Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils.	FBN1 FBN2	5.36e-06	2	81	2	21440062
Pubmed	MAGP-2 has multiple binding regions on fibrillins and has covalent periodic association with fibrillin-containing microfibrils.	FBN1 FBN2	5.36e-06	2	81	2	15131124
Pubmed	Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development.	FBN1 FBN2	5.36e-06	2	81	2	12524050
Pubmed	Microfibril structure masks fibrillin-2 in postnatal tissues.	FBN1 FBN2	5.36e-06	2	81	2	20404337
Pubmed	Fibrillln mutations in Marfan syndrome and related phenotypes.	FBN1 FBN2	5.36e-06	2	81	2	8791520
Pubmed	Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation.	RXRA RXRB	5.36e-06	2	81	2	24810760
Pubmed	Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices.	FBN1 FBN2	5.36e-06	2	81	2	8120105
Pubmed	The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.	FBN1 FBN2	5.36e-06	2	81	2	35419902
Pubmed	Limited degradation of retinoid X receptor by calpain.	RXRA RXRB	5.36e-06	2	81	2	8780715
Pubmed	Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18.	FBN1 FBN2	5.36e-06	2	81	2	8307578
Pubmed	Fibrillin assembly: dimer formation mediated by amino-terminal sequences.	FBN1 FBN2	5.36e-06	2	81	2	10504303
Pubmed	Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells.	RXRA RXRB	5.36e-06	2	81	2	20798333
Pubmed	Dysfunction of the RAR/RXR signaling pathway in the forebrain impairs hippocampal memory and synaptic plasticity.	RXRA RXRB	5.36e-06	2	81	2	22316320
Pubmed	Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils.	FBN1 FBN2	5.36e-06	2	81	2	7744963
Pubmed	Fibrillin microfibrils in bone physiology.	FBN1 FBN2	5.36e-06	2	81	2	26408953
Pubmed	Inhibition of the methyltranferase EZH2 improves aortic performance in experimental thoracic aortic aneurysm.	FBN1 EZH2	5.36e-06	2	81	2	29515022
Pubmed	Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration.	FBN1 FBN2	5.36e-06	2	81	2	18006876
Pubmed	Genetic variant of RXR involved in the vitamin D metabolic pathway was linked to HCV infection outcomes among a high-risk Chinese population.	RXRA RXRB	5.36e-06	2	81	2	33246082
Pubmed	Endogenous retinoid X receptor ligands in mouse hematopoietic cells.	RXRA RXRB	5.36e-06	2	81	2	29089448
Pubmed	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.	FBN1 FBN2	5.36e-06	2	81	2	24833718
Pubmed	Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata.	RXRA RXRB	5.36e-06	2	81	2	17341859
Pubmed	Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome.	FBN1 FBN2	5.36e-06	2	81	2	24265020
Pubmed	In vivo studies of mutant fibrillin-1 microfibrils.	FBN1 FBN2	5.36e-06	2	81	2	20529844
Pubmed	Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.	ATRX EZH2	5.36e-06	2	81	2	9499421
Pubmed	Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development.	FBN1 FBN2	5.36e-06	2	81	2	25524144
Pubmed	Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin.	RXRA RXRB	5.36e-06	2	81	2	16199515
Pubmed	MLL1:EZH2 Ratio in Uterine Secretions and Endometrial Receptivity in Patients with Endometriosis.	KMT2A EZH2	5.36e-06	2	81	2	36094360
Pubmed	Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions.	FBN1 FBN2	5.36e-06	2	81	2	23133647
Pubmed	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	FBN1 FBN2	5.36e-06	2	81	2	16407178
Pubmed	Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.	FBN1 FBN2	5.36e-06	2	81	2	1852206
Pubmed	A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development.	RXRA RXRB	5.36e-06	2	81	2	19255444
Pubmed	N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.	FBN1 FBN2	5.36e-06	2	81	2	10359653
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZNF462 ZMAT5 ZNF326 ZNF780A TRPS1 KMT2A PHF14 CHAMP1 RXRA RXRB	5.94e-06	709	81	10	22988430
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NCBP2 PHF2 PPP1R10 ZNF326 ATRX PCNX3 PDLIM7 CDC16 TRPS1 KMT2A PHF14 EZH2 CASZ1 ZMYM4	8.61e-06	1497	81	14	31527615
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NCBP2 PHF2 PPP1R10 ZNF326 ATRX CDC16 KMT2A PHF14 PHF8 EZH2 CHAMP1 CASZ1 ZMYM4	8.81e-06	1294	81	13	30804502
Pubmed	Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.	FBN1 FBN2 ADAMTS6	9.68e-06	18	81	3	35503090
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	ZNF462 TRPS1 ZNF362 CHAMP1 ZMYM4	1.14e-05	125	81	5	32891193
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ZNF462 ZNF326 ATRX CHAMP1 CASZ1 ZMYM4	1.31e-05	220	81	6	35785414
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PPP1R10 ZNF384 TRPS1 KMT2A PHF8 EZH2 CHAMP1	1.53e-05	341	81	7	32971831
Pubmed	Interaction of tropoelastin with the amino-terminal domains of fibrillin-1 and fibrillin-2 suggests a role for the fibrillins in elastic fiber assembly.	FBN1 FBN2	1.60e-05	3	81	2	10825173
Pubmed	Unique response pathways are established by allosteric interactions among nuclear hormone receptors.	RXRA RXRB	1.60e-05	3	81	2	7758108
Pubmed	The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.	RXRA RXRB	1.60e-05	3	81	2	9727070
Pubmed	PHD finger protein 2 (PHF2) represses ribosomal RNA gene transcription by antagonizing PHF finger protein 8 (PHF8) and recruiting methyltransferase SUV39H1.	PHF2 PHF8	1.60e-05	3	81	2	25204660
Pubmed	Cooperative formation of high-order oligomers by retinoid X receptors: an unexpected mode of DNA recognition.	RXRA RXRB	1.60e-05	3	81	2	7831303
Pubmed	Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma.	RXRA RXRB	1.60e-05	3	81	2	19188585
Pubmed	An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita.	RXRA RXRB	1.60e-05	3	81	2	7990953
Pubmed	Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1.	RXRA RXRB	1.60e-05	3	81	2	27184385
Pubmed	Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage.	FBN1 FBN2	1.60e-05	3	81	2	30201140
Pubmed	Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.	RXRA RXRB	1.60e-05	3	81	2	1312497
Pubmed	Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.	RXRA RXRB	1.60e-05	3	81	2	19897601
Pubmed	Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China.	RXRA RXRB	1.60e-05	3	81	2	18375961
Pubmed	Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies.	RXRA RXRB	1.60e-05	3	81	2	7980510
Pubmed	Differential regulation of ligand-dependent and ligand-independent functions of the mouse retinoid X receptor beta by alternative splicing.	RXRA RXRB	1.60e-05	3	81	2	10049761
Pubmed	Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate.	RXRA RXRB	1.60e-05	3	81	2	12514092
Pubmed	Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects.	RXRA RXRB	1.60e-05	3	81	2	11053444
Pubmed	Retinoid X receptors: X-ploring their (patho)physiological functions.	RXRA RXRB	1.60e-05	3	81	2	15608692
Pubmed	Chromosomal localization of the human retinoid X receptors.	RXRA RXRB	1.60e-05	3	81	2	8034312
Pubmed	Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.	KMT2A EZH2	1.60e-05	3	81	2	26431491
Pubmed	Differential 9-cis-retinoic acid-dependent transcriptional activation by murine retinoid X receptor alpha (RXR alpha) and RXR beta. Role of cell type and RXR domains.	RXRA RXRB	1.60e-05	3	81	2	8631847
Pubmed	Retinoid receptors trigger neuritogenesis in retinal degenerations.	RXRA RXRB	1.60e-05	3	81	2	21940995
Pubmed	The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.	RXRA RXRB	1.60e-05	3	81	2	11839661
Pubmed	Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.	RXRA RXRB	1.60e-05	3	81	2	18217139
Pubmed	Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.	FBN1 FBN2	1.60e-05	3	81	2	20855508
Pubmed	RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.	RXRA RXRB	1.60e-05	3	81	2	8799145
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NCBP2 ZNF326 FBN2 PCNX3 CDC16 CTSC LRRK2 MICAL3 ZNF841 EZH2 CHAMP1 RXRA	2.40e-05	1215	81	12	15146197
Pubmed	The Polycomb-Dependent Epigenome Controls β Cell Dysfunction, Dedifferentiation, and Diabetes.	KMT2A EZH2	3.20e-05	4	81	2	29754954
Pubmed	Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors.	RXRA RXRB	3.20e-05	4	81	2	8670810
Pubmed	Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.	FBN1 FBN2	3.20e-05	4	81	2	12429738
Pubmed	Polycomb repressive complex 2 is required for MLL-AF9 leukemia.	KMT2A EZH2	3.20e-05	4	81	2	22396593
Pubmed	Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.	RXRA RXRB	3.20e-05	4	81	2	1310259
Pubmed	Human eye development is characterized by coordinated expression of fibrillin isoforms.	FBN1 FBN2	3.20e-05	4	81	2	25406291
Pubmed	Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice.	RXRA RXRB	3.20e-05	4	81	2	10079186
Pubmed	Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.	RXRA RXRB	3.20e-05	4	81	2	8524212
Pubmed	Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.	FBN1 FBN2	3.20e-05	4	81	2	20729550
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN2	3.20e-05	4	81	2	25034023
Pubmed	Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients' Survival, and Retinoid X Receptor Expression.	RXRA RXRB	3.20e-05	4	81	2	26355550
Pubmed	Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes.	FBN1 FBN2	3.20e-05	4	81	2	16835936
Pubmed	Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.	RXRA RXRB	3.20e-05	4	81	2	19686701
Pubmed	Retinoid X receptors are essential for early mouse development and placentogenesis.	RXRA RXRB	3.20e-05	4	81	2	9892670
Pubmed	Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells.	RXRA RXRB	3.20e-05	4	81	2	9348290
Pubmed	Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.	RXRA RXRB	3.20e-05	4	81	2	25574839
Interaction	H3C3 interactions	ZNF462 PHF2 ZNF384 ATRX ZNF780A KMT2A PHF14 ZNF362 PHF8 EZH2 CHAMP1 ZMYM4	4.86e-07	495	79	12	int:H3C3
Interaction	H3-3A interactions	PHF2 PPP1R10 ZNF384 ATRX ZNF780A LRRK2 KMT2A PHF14 ZNF362 PHF8 EZH2 CHAMP1 CASZ1 ZMYM4	1.13e-06	749	79	14	int:H3-3A
Interaction	ASF1A interactions	PHF2 ZNF384 ATRX TRPS1 KMT2A PHF14 ZNF362 CASZ1	5.94e-06	249	79	8	int:ASF1A
Interaction	TRIM28 interactions	ZNF462 ZNF326 ZNF573 PPP6C ATRX ZNF780A ZNF616 ZNF264 ZNF749 ZNF841 DCTN4 EZH2 CHAMP1 ZNF416 ZNF529 ZNF354C ZMYM4 ZNF77	1.21e-05	1474	79	18	int:TRIM28
Interaction	CENPA interactions	ZNF462 PHF2 ZNF384 ATRX KMT2A PHF14 ZNF362 PHF8 CASZ1	1.66e-05	377	79	9	int:CENPA
Interaction	MEN1 interactions	ZNF462 PPP1R10 ZNF384 ZNF326 ATRX CDC16 TRPS1 KMT2A DCTN4 PHF8 EZH2 CHAMP1 ZMYM4 STT3A	4.17e-05	1029	79	14	int:MEN1
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF573 ZNF780A ZNF347 ZNF616 ZNF264 ZNF749 ZNF841 ZNF416 ZNF548 GARRE1 ZNF529	7.96e-06	1192	81	11	chr19q13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF462 ZNF384 ZNF326 ZNF573 ZFAT ZNF780A TRPS1 ZNF347 ZNF616 ZNF264 ZNF215 ZNF749 ZNF362 ZNF841 ZNF236 CHAMP1 ZNF416 ZNF548 ZNF529 ZNF354C CASZ1 ZNF710 ZNF77	1.30e-15	718	70	23	28
GeneFamily	Dyneins, axonemal	DNAH17 DNAH2 DNAH9	3.64e-05	17	70	3	536
GeneFamily	PHD finger proteins	PHF2 KMT2A PHF14 PHF8	4.10e-04	90	70	4	88
GeneFamily	LIM domain containing	PDLIM7 MICAL2 MICAL3	1.55e-03	59	70	3	1218
GeneFamily	PHD finger proteins\|Lysine demethylases	PHF2 PHF8	3.86e-03	24	70	2	485
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ZNF462 TUT4 THSD7A ATRX ASIC2 LRRK2 DLG2 ZNF264 MICAL3 PLCB4 FRMPD3 GABBR2 VPS53 CASZ1 VAV2 NPNT ZNF77 CEMIP	5.77e-09	1106	81	18	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TUT4 ATP2C1 ATRX MICAL2 CDC16 PHF14 MICAL3 PLCB4 PHF8 GARRE1 CNOT4 ZMYM4 CEMIP	2.12e-06	856	81	13	M4500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	C17orf75 TUT4 ATRX ADAMTS6 ZNF616 PHF14 MICAL3 DCTN4 VPS53 GDF11 CNOT4 ZMYM4	2.96e-05	780	79	12	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ZNF462 USP51 DNAH2 ZNF616 PHF14 EZH2 GDF11	6.76e-05	271	79	7	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	USP51 DNAH2 ZNF616 PHF14 EZH2 GDF11	6.82e-05	186	79	6	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	ZNF462 TUT4 USP51 TRPS1 DNAH2 ZNF616 PHF14 EZH2 GDF11	8.74e-05	492	79	9	Facebase_RNAseq_e10.5_Mandibular Arch_500
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF326 CDC16 CTSC LRRK2 RXRB BBS10	6.38e-07	168	81	6	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FBN1 FBN2 ADAMTS6 TRPS1 PLCB4 NPNT	1.19e-06	187	81	6	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FBN1 MICAL3 VAV2 SVEP1 NPNT CEMIP	1.48e-06	194	81	6	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FBN2 DOCK11 CTSC DNAH17 LRRK2 NPNT	1.48e-06	194	81	6	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZFAT HPR DNAH2 MUC5B DNAH9 SPINK5	1.71e-06	199	81	6	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZFAT HPR DNAH2 MUC5B DNAH9 SPINK5	1.71e-06	199	81	6	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZFAT HPR DNAH2 MUC5B DNAH9 SPINK5	1.76e-06	200	81	6	cf191104484bfb2b9f87de416b9453135f8833c1
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	HPR DNAH2 MUC5B SLC9C2 DNAH9 SPINK5	1.76e-06	200	81	6	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA-Epithelial_airway\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZFAT HPR DNAH2 MUC5B DNAH9 SPINK5	1.76e-06	200	81	6	a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	HPR DNAH2 MUC5B SLC9C2 DNAH9 SPINK5	1.76e-06	200	81	6	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FBN2 DOCK11 LRRK2 DLG2 NPNT	8.86e-06	153	81	5	d6526d17826470534b766df144c74e73eb83fdad
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A TRPS1 CASZ1 NPNT CEMIP	1.24e-05	164	81	5	f0499e6c1b17c4df72b18b294e3b53ef723da2ac
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	C17orf75 ZNF573 ZNF780A DOCK11 ZNF416	1.60e-05	173	81	5	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 FBN2 DOCK11 DNAH17 LRRK2	1.74e-05	176	81	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP51 ADAMTS6 ZNF362 CHAMP1 CASZ1	1.79e-05	177	81	5	b8de0fc92691a6d6759c743195b11edd2d63f265
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|368C / Donor, Lineage, Cell class and subclass (all cells)	PHF2 PPP6C PHF8 ZNF236 ZNF354C	1.94e-05	180	81	5	551b8de8d933d11bcd3897aeb2fd033355f958e2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A ASIC2 DLG2 CASZ1 VAV2	1.99e-05	181	81	5	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBN2 DOCK11 LRRK2 DLG2 NPNT	1.99e-05	181	81	5	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 FBN2 DOCK11 LRRK2 NPNT	2.05e-05	182	81	5	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZNF462 CTSC TRPS1 PLCB4 CEMIP	2.05e-05	182	81	5	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A DLG2 DNAH9 CASZ1 NPNT	2.10e-05	183	81	5	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A DLG2 DNAH9 CASZ1 NPNT	2.10e-05	183	81	5	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZNF462 THSD7A LRRK2 NPNT CEMIP	2.16e-05	184	81	5	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FBN1 FBN2 TRPS1 PLCB4 NPNT	2.21e-05	185	81	5	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FBN1 ADAMTS6 TRPS1 PLCB4 NPNT	2.21e-05	185	81	5	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 FBN2 DOCK11 LRRK2 NPNT	2.27e-05	186	81	5	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 DOCK11 LRRK2 DLG2 MICAL3	2.33e-05	187	81	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBN1 THSD7A ADAMTS6 PLCB4 GARRE1	2.45e-05	189	81	5	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	ZFAT USP51 ZNF362 ZNF548 NPNT	2.58e-05	191	81	5	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A ADAMTS6 DOCK11 FRMPD3 VAV2	2.65e-05	192	81	5	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 PDLIM7 MICAL2 SVEP1 CEMIP	2.71e-05	193	81	5	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 PDLIM7 MICAL2 SVEP1 CEMIP	2.71e-05	193	81	5	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MICAL2 LRRK2 DLG2 CASZ1 NPNT	2.78e-05	194	81	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FBN1 DOCK11 CTSC PLCB4 SPINK5	2.99e-05	197	81	5	143607d195c8aa2b94d995af0b2ef38582565611
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZFAT HPR DNAH2 MUC5B SPINK5	3.07e-05	198	81	5	6712216c5a7fd86b68fd45b0ff7794975f19774e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ZNF462 TUT4 ATRX KMT2A PHF14	3.07e-05	198	81	5	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TUT4 ATRX KMT2A PLCB4 GARRE1	3.22e-05	200	81	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FBN2 THSD7A DOCK11 DNAH17 VAV2	3.22e-05	200	81	5	f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FBN2 THSD7A ADAMTS6 DOCK11 VAV2	3.22e-05	200	81	5	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FBN2 THSD7A DOCK11 DNAH17 VAV2	3.22e-05	200	81	5	70a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FBN1 THSD7A ADAMTS6 PLCB4 GARRE1	3.22e-05	200	81	5	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	FBN1 THSD7A ADAMTS6 PLCB4 GARRE1	3.22e-05	200	81	5	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FBN1 THSD7A ADAMTS6 PLCB4 GARRE1	3.22e-05	200	81	5	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FBN2 THSD7A DOCK11 DNAH17 VAV2	3.22e-05	200	81	5	1639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FBN1 THSD7A ADAMTS6 PLCB4 GARRE1	3.22e-05	200	81	5	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 LRRK2 MUC5B CASZ1	1.08e-04	135	81	4	8521107817df49efd9a2e81078c8535ed33e729c
ToppCell	lung-Type_II_Pneumocytes\|lung / shred on tissue and cell subclass	MICAL2 CTSC LRRK2 NPNT	1.50e-04	147	81	4	8a3039de45b8087f8319e2e37329acf7278219b7
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF462 FBN2 ADAMTS6 NPNT	1.97e-04	158	81	4	6d2709b387945c015faa223c20d22b52a4082140
ToppCell	ASK440-Immune-B_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	TUT4 ZFAT DTWD1 ZNF215	2.02e-04	159	81	4	d31eb59c1b5948df721b829b9a7e806f27cbd41c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN2 MUC5B DNAH9 SVEP1	2.07e-04	160	81	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	ADAMTS6 PDLIM7 MICAL3 PLCB4	2.07e-04	160	81	4	d783d29150033e9181c0e30870070268fed3fd85
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN2 MUC5B DNAH9 SVEP1	2.07e-04	160	81	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 MUC5B DNAH9 SPINK5	2.28e-04	164	81	4	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A CASZ1 NPNT CEMIP	2.38e-04	166	81	4	b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN1 FBN2 CTSC SVEP1	2.55e-04	169	81	4	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DTWD1 DOCK11 DNAH17 LRRK2	2.61e-04	170	81	4	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CTSC TRPS1 NPNT	2.79e-04	173	81	4	61907116a1460bc157ba73b5edd108db7dd5de4b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CTSC TRPS1 NPNT	2.79e-04	173	81	4	d17e50dc400098374af626803dec1241ec566769
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF384 DOCK11 LRRK2 CASZ1	2.91e-04	175	81	4	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 FBN2 DOCK11 LRRK2	2.91e-04	175	81	4	284fdc7a9d303636a637041846850d19d114861a
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TUT4 ADAMTS6 VAV2 ZNF710	2.98e-04	176	81	4	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CTSC TRPS1 NPNT	2.98e-04	176	81	4	4843af68f013732c28a8b8edad30d5fa0f2b084b
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 THSD7A GABBR2 SVEP1	2.98e-04	176	81	4	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CTSC TRPS1 NPNT	2.98e-04	176	81	4	95d5a4fdff1b9c715636684d22e06f8727ac0e7a
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 THSD7A GABBR2 SVEP1	2.98e-04	176	81	4	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 DLG2 SVEP1 NPNT	3.04e-04	177	81	4	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD7A ADAMTS6 PLCB4 MAP3K6	3.04e-04	177	81	4	5ff8dcfb030312126695d53a026d2e104a401b83
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN2 PDLIM7 TRPS1 NPNT	3.04e-04	177	81	4	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBN1 MICAL2 ZNF841 SVEP1	3.04e-04	177	81	4	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R10 ATRX PLCB4 CNOT4	3.11e-04	178	81	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS6 PDLIM7 HPR GARRE1	3.11e-04	178	81	4	e2363810d77b6b245394a666eb51bacd345c43f7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CTSC TRPS1 NPNT	3.17e-04	179	81	4	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBN1 THSD7A ADAMTS6 PLCB4	3.17e-04	179	81	4	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS6 DNAH2 FRMPD3 SVEP1	3.17e-04	179	81	4	0b6731d9554f8bed1899c165a50e6b329ea19a6d
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CTSC TRPS1 DLG2 PLCB4	3.17e-04	179	81	4	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 TRPS1 PLCB4 VAV2	3.24e-04	180	81	4	e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FBN2 THSD7A DOCK11 VAV2	3.31e-04	181	81	4	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A DOCK11 LRRK2 PLCB4	3.31e-04	181	81	4	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 TRPS1 PLCB4 VAV2	3.38e-04	182	81	4	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 TRPS1 PLCB4 VAV2	3.38e-04	182	81	4	05c167158815bf25d509df59ab386e1990712765
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBN2 DOCK11 DNAH17 LRRK2	3.45e-04	183	81	4	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 THSD7A MICAL2 PLCB4	3.45e-04	183	81	4	351d575339038bd4a66f408da518c567444208e8
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN2 ADAMTS6 PDLIM7 NPNT	3.45e-04	183	81	4	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	DOCK11 DLG2 ZNF354C SVEP1	3.52e-04	184	81	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP1R10 TUT4 ATRX KMT2A	3.52e-04	184	81	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MICAL2 CTSC LRRK2 NPNT	3.52e-04	184	81	4	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A DLG2 CASZ1 NPNT	3.52e-04	184	81	4	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	FBN1 FBN2 ADAMTS6 PDLIM7	3.60e-04	185	81	4	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A ADAMTS6 FRMPD3 SVEP1	3.60e-04	185	81	4	cefd81adb480c027545a5c78dcd05669783717f4
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	FBN1 DLG2 SVEP1 CEMIP	3.60e-04	185	81	4	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Mild-Lymphoid-pDC\|Mild / Condition, Lineage, Cell class and cell subclass	ZFAT PLCB4 TLR9 SLC9C2	3.67e-04	186	81	4	7fa82972c726025d6402e5eb7bf0db3b699eba4c
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FBN1 FBN2 TRPS1 PLCB4	3.67e-04	186	81	4	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZFAT PLCB4 TLR9 SLC9C2	3.67e-04	186	81	4	b031f4e6867b6200b85f43276a34749bf5f4603f
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZFAT PLCB4 TLR9 SLC9C2	3.67e-04	186	81	4	d2fbf53aac905c9896272ec5c2db28ee1a60f4be
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF462 DOCK11 LRRK2 MICAL3	3.67e-04	186	81	4	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	Mild-Lymphoid-pDC-\|Mild / Condition, Lineage, Cell class and cell subclass	ZFAT PLCB4 TLR9 SLC9C2	3.67e-04	186	81	4	1d05e73ae2ec0cc27f79e4fa40d6b21790059f80
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZFAT PLCB4 TLR9 SLC9C2	3.67e-04	186	81	4	79aedd5aed72509a4925e9f6cb43bc0c798c86f5
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MICAL2 CTSC LRRK2 NPNT	3.67e-04	186	81	4	e83718fabb057100835d3357df407f283d23fe16
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FBN1 ADAMTS6 TRPS1 PLCB4	3.75e-04	187	81	4	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADAMTS6 CTSC EZH2 CASZ1	3.75e-04	187	81	4	d17352f769c3c66601b65d060626eecff41b0482
Computational	Neighborhood of GSPT1	PHF2 ZNF384 ATP2C1 KMT2A DCTN4 VPS53 ZNF529	8.97e-06	169	48	7	GCM_GSPT1
Computational	Neighborhood of RBM8A	PHF2 ZNF384 KMT2A DCTN4 ZNF529	2.85e-05	81	48	5	GCM_RBM8A
Computational	Neighborhood of MLL	PHF2 ZNF384 KMT2A CHAMP1 VPS53 ZNF529	1.15e-04	174	48	6	GCM_MLL
Computational	Neighborhood of NCAM1	ZNF462 PHF2 DCTN4 GABBR2 ZNF529	2.43e-04	127	48	5	GCM_NCAM1
Computational	Neighborhood of SUFU	PHF2 KMT2A DCTN4 ZNF529	3.73e-04	77	48	4	GCM_SUFU
Computational	Neighborhood of UBE2N	PHF2 ZNF384 KMT2A DCTN4 ZNF529	5.89e-04	154	48	5	GCM_UBE2N
Computational	Neighborhood of MYST2	ZNF462 PHF2 ZNF384 DCTN4 ZNF529	9.71e-04	172	48	5	GCM_MYST2
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	ZMAT5 DTWD1 PDLIM7 PHF8 DNAH9 ZNF710 CEMIP	6.39e-06	196	81	7	5863_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	PDLIM7 MICAL2 KMT2A ZNF749 GABBR2 CNOT4 CEMIP	6.61e-06	197	81	7	3798_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A	FBN1 PDLIM7 DNAH17 PHF8 GABBR2 CASZ1 ZNF710	6.83e-06	198	81	7	3067_UP
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A	ATP2C1 PDLIM7 TRPS1 TTLL1 ZNF215 GABBR2 ZNF710	6.83e-06	198	81	7	3051_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PHF2 DTWD1 TRPS1 ZNF236 RXRA ZNF710	2.83e-05	166	81	6	7324_DN
Drug	Bexarotene	RXRA RXRB	3.74e-05	3	81	2	DB00307
Drug	2-hydroxyphytanic acid	RXRA RXRB	3.74e-05	3	81	2	ctd:C002585
Drug	AC1O5SBP	RXRA RXRB	3.74e-05	3	81	2	CID006439746
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	ZNF573 ATRX PDLIM7 MICAL2 GARRE1 RXRA	6.76e-05	194	81	6	6555_DN
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	ZNF236 VPS53 CASZ1 VAV2 SPINK5 CEMIP	6.76e-05	194	81	6	5342_UP
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ZMAT5 ZNF573 PDLIM7 PHF8 GABBR2 CNOT4	6.76e-05	194	81	6	5630_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	FBN1 PDLIM7 ZNF362 CNOT4 VAV2 ZNF710	6.96e-05	195	81	6	4705_UP
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	PDLIM7 TTLL1 PHF8 GABBR2 VPS53 GARRE1	6.96e-05	195	81	6	5103_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; HL60; HT_HG-U133A	DNAH17 KMT2A TTLL1 ZNF215 PLCB4 CNOT4	6.96e-05	195	81	6	2971_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A	PDLIM7 VPS53 RXRA ZMYM4 ZNF710 SPINK5	6.96e-05	195	81	6	5245_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A	ZMAT5 FBN2 PDLIM7 CDC16 PLCB4 BBS10	7.16e-05	196	81	6	2506_DN
Drug	Ro 15-0778	HPR RXRA RXRB	7.30e-05	23	81	3	CID006436116
Drug	Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A	FBN2 PDLIM7 MUC5B VPS53 VAV2 CEMIP	7.36e-05	197	81	6	3201_UP
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A	PDLIM7 MICAL2 KMT2A PHF14 GABBR2 VPS53	7.36e-05	197	81	6	6703_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	PHF2 FBN2 PDLIM7 MICAL3 ZNF215 VPS53	7.36e-05	197	81	6	2484_DN
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; PC3; HT_HG-U133A	ZMAT5 ZNF573 KMT2A ZNF215 ZNF362 VAV2	7.36e-05	197	81	6	6622_UP
Drug	AGN 190727	RXRA RXRB	7.47e-05	4	81	2	CID006439768
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	ATRX PDLIM7 GABBR2 VPS53 RXRA CNOT4	7.57e-05	198	81	6	3754_DN
Drug	Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ZNF573 ATRX PDLIM7 MICAL2 MAP3K6 CASZ1	7.57e-05	198	81	6	7216_DN
Drug	Piroxicam [36322-90-4]; Up 200; 12uM; HL60; HG-U133A	PHF2 ATP2C1 PITPNA EZH2 CASZ1 ZNF710	7.57e-05	198	81	6	1405_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	FBN2 PDLIM7 KMT2A ZNF215 VPS53 ZNF710	7.78e-05	199	81	6	3115_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	TUT4 THSD7A TTLL1 ZNF236 GABBR2 SVEP1	8.00e-05	200	81	6	6002_UP
Drug	7-methoxycitronellal	RXRA RXRB	1.24e-04	5	81	2	CID000019223
Drug	7-methoxycitronellic acid	RXRA RXRB	1.24e-04	5	81	2	CID000171516
Drug	13,14-dihydroretinol	RXRA RXRB	1.24e-04	5	81	2	CID000446798
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN2	1.96e-05	3	76	2	DOID:65 (implicated_via_orthology)
Disease	scoliosis (is_implicated_in)	FBN1 FBN2	3.92e-05	4	76	2	DOID:0060249 (is_implicated_in)
Disease	Weaver syndrome	KMT2A EZH2	6.51e-05	5	76	2	C0265210
Disease	factor VIII measurement, coagulation factor measurement	ASIC2 VAV2	6.51e-05	5	76	2	EFO_0004630, EFO_0004634
Disease	response to bronchodilator, response to corticosteroid	ZNF616 ZNF841	6.51e-05	5	76	2	GO_0031960, GO_0097366
Disease	acute lymphoblastic leukemia (implicated_via_orthology)	KMT2A EZH2	9.75e-05	6	76	2	DOID:9952 (implicated_via_orthology)
Disease	central corneal thickness	FBN1 FBN2 ADAMTS6 KMT2A RXRA VAV2	1.48e-04	309	76	6	EFO_0005213
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	PHF2 PHF8	1.81e-04	8	76	2	DOID:0060309 (implicated_via_orthology)
Disease	myelofibrosis (is_implicated_in)	KMT2A EZH2	1.81e-04	8	76	2	DOID:4971 (is_implicated_in)
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	DLG2 SLC9C2 VPS53 VAV2	1.91e-04	110	76	4	EFO_0003095, MONDO_0005148
Disease	Agents acting on the renin-angiotensin system use measurement	FBN2 CDC16 TRPS1 CASZ1 SVEP1 NPNT	2.30e-04	335	76	6	EFO_0009931
Disease	vascular endothelial growth factor measurement	ZNF462 DNAH2 ZNF710	4.13e-04	56	76	3	EFO_0004762
Disease	thyroxine measurement, triiodothyronine measurement	ZNF616 ZNF841	8.68e-04	17	76	2	EFO_0005130, EFO_0008392
Disease	sinusitis (is_marker_for)	MUC5B TLR9	9.75e-04	18	76	2	DOID:0050127 (is_marker_for)
Disease	4-ethylphenylsulfate measurement	DTWD1 ADAMTS6	9.75e-04	18	76	2	EFO_0021148
Disease	insomnia measurement	PHF2 PPP1R10 TRPS1 KMT2A DLG2 PHF14	9.98e-04	443	76	6	EFO_0007876
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 DNAH9	1.09e-03	19	76	2	DOID:10003 (implicated_via_orthology)
Disease	corneal resistance factor	FBN1 FBN2 ADAMTS6 KMT2A RXRA VAV2	1.09e-03	451	76	6	EFO_0010067
Disease	cardiovascular disease	FBN2 HPR DLG2 CASZ1 SVEP1 NPNT	1.17e-03	457	76	6	EFO_0000319
Disease	Craniosynostosis	ZNF462 EZH2	1.21e-03	20	76	2	C0010278
Disease	female reproductive system disease	ASIC2 GABBR2	1.60e-03	23	76	2	EFO_0009549
Disease	mean arterial pressure	FBN2 PCNX3 RXRA CASZ1 SVEP1 NPNT	1.83e-03	499	76	6	EFO_0006340
Disease	response to TNF antagonist, joint damage measurement	DLG2 GABBR2	1.89e-03	25	76	2	EFO_0004653, EFO_0005413
Disease	intraocular pressure measurement	FBN1 FBN2 THSD7A ADAMTS6 KMT2A RXRA	2.02e-03	509	76	6	EFO_0004695
Disease	Antiglaucoma preparations and miotics use measurement	THSD7A KMT2A	2.04e-03	26	76	2	EFO_0009944
Disease	Calcium channel blocker use measurement	FBN2 CASZ1 SVEP1 NPNT	2.26e-03	213	76	4	EFO_0009930
Disease	Hematopoetic Myelodysplasia	ATRX EZH2	2.54e-03	29	76	2	C2713368

Protein segments in the cluster

Peptide	Gene	Start	Entry
YKCMECGKAYSYRSN	ZNF354C	496	Q86Y25
AYMTKCGHSFCYKCI	COP1	146	Q8NHY2
RENCGYKFCGRTHMY	CASZ1	1461	Q86V15
DYFFKCMTCKSGIGV	BBS10	196	Q8TAM1
ICSGCYAQMYIQAYK	CEMIP	996	Q8WUJ3
ICFMKGAYEQVIKYC	ATP2C1	476	P98194
LKFKFCSRAYFRQMC	ADAMTS6	1096	Q9UKP5
VFTKYGKCYMFNSGE	ASIC2	186	Q16515
GKFKMCFNYEIRVFC	MUC5B	2951	Q9HC84
GKFKMCFNYEIRVFC	MUC5B	3651	Q9HC84
DCPYMCAYKLVTVKF	PITPNA	186	Q00169
SDTCYFCQKRVYVME	MICAL3	761	Q7RTP6
MKKTACGFCFVEYYS	NCBP2	76	P52298
KHRCMNTYGSYKCYC	NPNT	101	Q6UXI9
DGKFYTNKCYMCRAV	SPINK5	941	Q9NQ38
FCVGMSKYQEDTCYG	HPR	281	P00739
DLYCMCGRIYKDMFF	MAP3K6	351	O95382
ADRRGKVYDKYMCSF	EZH2	651	Q15910
KYCFYCRALLMTVAG	PCNX3	1171	Q9H6A9
ADYGIAQYCCRMGIK	LRRK2	2016	Q5S007
ALFKCYMFLKNCGSG	C17orf75	346	Q9HAS0
PYCERDYEKMFGTKC	PDLIM7	386	Q9NR12
MNYSKYGAKECSFCE	PHF14	431	O94880
HYYNCDFKMCYKLTS	CDC16	241	Q13042
ICKNCFKYYMSDDIS	ATRX	196	P46100
FFKGRVNMCAAFCYE	DOCK11	1471	Q5JSL3
TYDFCCVNMKLFFKD	DNAH17	386	Q9UFH2
KNTMGSYRCLCKEGY	FBN1	1381	P35555
LRMSYCYAKFEGGKC	FBN1	2056	P35555
YMKRGKGKYYCKICC	CHAMP1	701	Q96JM3
SIRYCFYYRKCDMAD	FRMPD3	1526	Q5JV73
MYCCSAQDSKMDYKR	GARRE1	1	O15063
YKANYCSGQCEYMFM	GDF11	336	O95390
CKMKEDCFRYYSSEY	CTSC	331	P53634
AKVFCCAYEENMYGS	GABBR2	261	O75899
REKYYDSKGIGCYMF	KMT2A	3871	Q03164
MFFACYCALRTNVKK	DLG2	1	Q15700
CSEQMDYKSCGNIYK	DNAH9	1896	Q9NYC9
NCMDMRKSFCYRSYN	FBN2	1731	P35556
TTMKKAYYLACGFCR	DCTN4	101	Q9UJW0
RKKSAKGMYSCPCYY	DNAH2	4371	Q9P225
RCQYCRYQKCLAMGM	RXRA	186	P19793
SKCLKCGGSRMFYCY	DTWD1	56	Q8N5C7
TCYFCKKRVYVMERL	MICAL2	1001	O94851
HCSKYQQYKMSKYCE	PLCB4	411	Q15147
SEMFFADQVDKCYKC	PHF2	291	O75151
TKSCYDGQCYEYKWM	THSD7A	1466	Q9UPZ6
KMCYYRFGQVYTEAK	STT3A	641	P46977
AMVAYSCNKGFYIKG	SVEP1	2166	Q4LDE5
RCQYCRYQKCLATGM	RXRB	256	P28702
GCGTRYTVMAKNCYK	C10orf82	121	Q8WW14
GTTKYCSYFLKNMQC	CNOT4	191	O95628
KYFRCKFCNFTYMGN	TRPS1	331	Q9UHF7
GVIYCFMCKDYVYDK	USP51	281	Q70EK9
KTYRCRMCSLTFYSK	ZNF384	226	Q8TF68
ACKVCGKTFMYYSYL	ZNF77	241	Q15935
GKRAMKCPYCDFYFM	ZFAT	876	Q9P243
YQCDVCGKIFRKNSY	ZNF616	241	Q08AN1
YECNKCGKFFMYNSK	ZNF749	326	O43361
KTYECRQCGKAFIYA	ZNF573	216	Q86YE8
YCYRCGNIASIMVFK	PPP6C	261	O00743
FLFMDGNCYYKNPCR	TLR9	171	Q9NR96
QKMAKCAVQDYTYRG	SMRP1	61	Q8NCR6
QCRMCEKSYTSKYNL	ZNF710	296	Q8N1W2
VCKECGMAFRYHYQL	ZNF780A	306	O75290
CADLFVYYKKCMVQC	VPS53	471	Q5VIR6
YMCNECGKAFSVYSS	ZNF347	541	Q96SE7
NKCGMVFTYYSCLAR	ZNF841	456	Q6ZN19
CMECGKAFNRKSYLT	ZNF264	261	O43296
YVCGECGKAFMFKSK	ZNF416	466	Q9BWM5
MGKRYFCDYCDRSFQ	ZMAT5	1	Q9UDW3
MNSYECYQCGKAFCR	ZNF215	376	Q9UL58
RTYECRECGKSFMYN	ZNF548	251	Q8NEK5
KHAKAYCCSMCGRAY	ZNF362	366	Q5T0B9
LAMFTREDKYSCQYC	ZNF462	2016	Q96JM2
RPYKCAYCVMGFTQK	ZNF236	1776	Q9UL36
EMFFGDQVDKCYKCS	PHF8	326	Q9UPP1
GAAKCYYSIQGKFMS	SLC9C2	541	Q5TAH2
NCKACKMFLRGTFYQ	VAV2	536	P52735
PCKYMEYGNTCSFYK	ZNF529	226	Q6P280
QYLGYTMKVFAKRCD	TUT4	1096	Q5TAX3
MMKGNCRYENNCAFY	PPP1R10	916	Q96QC0
KMFQFCGKNCSDEYK	ZMYM4	706	Q5VZL5
YTVLFYQMAKCDACK	ZMYM4	806	Q5VZL5
CYMYKLGFCRFCTVK	TTLL1	211	O95922
DGYRMAFTCSFCKFR	ZNF326	306	Q5BKZ1